Serapha Bio

Serapha Bio is a clinical-stage biotechnology company developing a novel base editing therapy for patients with AATD.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2026
Serapha Bio logo
Serapha Bio Hover Image